Waste Or Feces (e.g., Slaughterhouse Offal, Chicken Feet, Horn, Hair, Hide, Urine, Etc.) Patents (Class 424/543)
  • Publication number: 20020122830
    Abstract: A method of determining an effective method for control of soil pathogens in a soil which includes the step of measuring the pH of the soil, measuring the organic carbon content of the soil, measuring the buffering capacity of the soil, adding a nitrogen containing material and a pH reducing agent to reduce the soil pH below 5.5 when the buffering capacity of the soil is below a predetermined amount, and adding a nitrogen containing material and a pH raising agent to raise the pH above 8.5 when the organic carbon content is less than 1.7% by weight.
    Type: Application
    Filed: December 14, 2001
    Publication date: September 5, 2002
    Inventors: Mario Tenuta, George Lazarovits
  • Patent number: 6417166
    Abstract: A strong, thin flexible mineralized collagen membrane is disclosed that is useful for such medical applications as a barrier for guided tissue regeneration, periodontal defect repair, bone grafts and skin wound repair. The mineralized collagen membrane comprises a substantially homogeneous mineralized collagen composite consisting essentially of about 30% to about 70% by weight of a collagen component and about 30% to about 70% by weight of a calcium phosphate minerals component precipitated from a collagen slurry by a soluble calcium ion-containing solution and a soluble phosphate ion-containing solution. The calcium phosphate minerals component has a mole ratio of calcium to phosphate in the range of about 1.0 to about 2.0. The thin mineralized collagen membrane has a bulk density of the membrane of at least about 1.0 g/cm3 and has a thickness not greater than about 0.5 mm and preferably not greater than about 0.3 mm.
    Type: Grant
    Filed: May 19, 2001
    Date of Patent: July 9, 2002
    Assignee: Ceramedical, Inc.
    Inventor: Sung-Tsuen Liu
  • Patent number: 6407038
    Abstract: A method for controlling Tylenchid plant-parasitic nematodes through application of an effective amount of an alkaline-stabilized sludge is described. In accordance with particular embodiments, the alkaline-stabilized sludge may be applied to the plant, seed or locus thereof.
    Type: Grant
    Filed: June 16, 2000
    Date of Patent: June 18, 2002
    Assignee: Her Majesty the Queen in right of Canada, as represented by c/o Minister of Agriculture and Agri-Food Canada
    Inventors: Thomas William Welacky, Edward Topp
  • Patent number: 6322783
    Abstract: The bacteriophage has a high level of specificity to a certain specific pathogenic bacterium so that the bacteriophage can surely kill the pathogenic bacterium as a host through phogocytic action. The bio-bactericidal material containing the bacteriophage can be applied to food such as fresh food, etc., and to places, etc. or to even persons for cooking food material such as restaurants, school kitchens, etc., or any other thing which requires disinfection from pathogenic bacteria, and it can kill pathogenic bacteria. The bio-bactericidal material containing a cocktail of two or more different kinds of the bacteriophages can kill corresponding kinds of pathogenic bacteria concurrently. Further, the phage can infect only the pathogenic bacterium as a host bacterium, and does not infect persons, making it very safe and useful.
    Type: Grant
    Filed: February 26, 1999
    Date of Patent: November 27, 2001
    Inventor: Seishi Takahashi
  • Patent number: 6300315
    Abstract: A thin, strong, flexible mineralized collagen membrane is disclosed that is useful for such medical applications as a barrier for guided tissue regeneration, periodontal defect repair, bone grafts and skin wound repair. The mineralized collagen membrane comprises a substantially homogeneous mineralized collagen composite consisting essentially of about 30% to about 70% by weight of a collagen component and about 30% to about 70% by weight of a calcium phosphate minerals component precipitated from a collagen slurry by a soluble calcium ion-containing solution and a soluble phosphate ion-containing solution. The calcium phosphate minerals component has a mole ratio of calcium to phosphate in the range of about 1.0 to about 2.0. The thin, strong, flexible mineralized collagen membrane has a bulk density of at least about 1.0 g/cm3.
    Type: Grant
    Filed: August 28, 1999
    Date of Patent: October 9, 2001
    Assignee: Ceramedical, Inc.
    Inventor: Sung-Tsuen Liu
  • Patent number: 6248367
    Abstract: Disclosed are bovine excretion extracts having anticancer and anti-inflammatory activity prepared by a process comprising the step of extracting bovine excretion with a polar solvent selected from the group consisting of lower alcohol, lower ketone, acetonitrile, water and mixtures thereof, a process for preparing the same, and the use thereof as an anticancer agent or adjuvant, or an anti-inflammatory agent.
    Type: Grant
    Filed: July 7, 1999
    Date of Patent: June 19, 2001
    Inventors: Bok Deuk Kim, Man Ki Park, Jeong Hill Park, Seung Ki Lee, Jin Ho Chung, Sung Won Park
  • Patent number: 6149901
    Abstract: The present invention relates to animal scent attractants. More particularly, the present invention relates to a composition of matter for amplifying and preserving animal scents. Fox urine, coyote urine, deer urine, elk urine, moose urine, bear urine, rabbit urine, fish oils, and sheep manure are examples of substances which can be used with the present invention.
    Type: Grant
    Filed: August 17, 1999
    Date of Patent: November 21, 2000
    Assignee: EBSCO Industries, Inc.
    Inventor: Mark J. Weiser
  • Patent number: 6099867
    Abstract: A nutraceutical composition comprising water insoluble antler powder or water soluble antler powder or a combination of both. Also disclosed is a method of producing antler powder, either water soluble, water insoluble or a combination of both.
    Type: Grant
    Filed: June 26, 1998
    Date of Patent: August 8, 2000
    Inventor: Jeong S. Sim
  • Patent number: 6093421
    Abstract: Testosterone levels in men are increased by the oral administration of powdered maca and antler.
    Type: Grant
    Filed: August 31, 1999
    Date of Patent: July 25, 2000
    Assignee: Biotics Research Corporation
    Inventors: Daryl L. DeLuca, William S. Sparks, Denis R. DeLuca
  • Patent number: 5891426
    Abstract: The invention concerns a procedure for testing a potentially-active substance used in the hair-care field, this procedure being characterized by the fact that a fragment of at least one hair follicle without dermal papilla is isolated, this fragment being taken from beneath the point of attachment of the sebaceous gland and excluding the portion of the hair shaft located above the point of attachment of the sebaceous gland; that this fragment is incubated in a suitable culture medium for a sufficient period; that this fragment is placed in contact with a potentially-active hair-care substance; that a marker of the activity of said tested substance is quantitatively determined; and that the results of this determination are assessed as they compare to a control.
    Type: Grant
    Filed: February 18, 1997
    Date of Patent: April 6, 1999
    Assignee: Societe L'Oreal S.A.
    Inventors: Fran.cedilla.oise Jarrousse, Stephane Commo, Olivier Gaillard, Bruno Bernard
  • Patent number: 5698228
    Abstract: There is provided a skin substitute that can suitably be used for covering the surface of a damaged skin area which is typically a wound produced by a traumatic local loss of the skin of the human body as a result of a burn or some other cause of damage. It is a skin substitute of a laminate comprising a squid chitin sheet and a fish skin collagen coat layer, which may be a salmon skin collagen coat layer. Such a skin substitute effectively exploits the suppleness and the effect of proving an environment for encouraging the production of lysozyme and defending the wound of squid chitin and, at the same time, compensate the disadvantage of poor adhesion of fibroblast cells that operate for curing the wound.
    Type: Grant
    Filed: June 25, 1996
    Date of Patent: December 16, 1997
    Assignees: Hokkaido Government, Daido Hoxan Inc.
    Inventors: Mitsuo Takai, Yuichi Shimizu, Josuke Shimizu, Kunio Yamazaki, Yoshiteru Kumabayashi, Hideki Shimizu, Kunishige Yamada
  • Patent number: 5690964
    Abstract: A non-toxic rodent deterrent made from dried fecal matter and/or dried urine from mammals of the Mustelidae Family (e.g. weasels, ferrets, minks, martens, etc.). The rodent deterrent material may be used in its bulk from or this material may be placed in a container for either interior or exterior use.
    Type: Grant
    Filed: November 6, 1996
    Date of Patent: November 25, 1997
    Inventor: Cindy J. Hill
  • Patent number: 5648065
    Abstract: The invention relates to cosmetic or pharmaceutical, particularly dermatological, compositions. More particularly, the invention relates to the utilization of an extract of coleus Esquirolii, coleus Scutellariodes or Coleus Xanthanthus or one of the mixtures thereof for the preparation of cosmetic or pharmaceutical, particularly dermatological, composition. In particular, the invention helps to efficiently promote skin or hair pigmentation.
    Type: Grant
    Filed: February 21, 1996
    Date of Patent: July 15, 1997
    Assignee: L.V.M.H. Recherche
    Inventors: Alain Meybeck, Frederic Bonte, Marc Dumas
  • Patent number: 5626881
    Abstract: Humate, a composition of primarily humic acids, carbon, and organic matter, is used as a human dietary supplement. The humate may be mixed with food, liquid drinks, or flavoring and ingested. The powder, granule, or water-soluble powder form of humate may also be mixed with other known dietary supplements such as multi-vitamins and be formed into capsules and tablets. The preferred humate is mined from the Menefee Geological Formation in Northwestern New Mexico.
    Type: Grant
    Filed: May 16, 1995
    Date of Patent: May 6, 1997
    Assignee: Menefee Mining Corporation
    Inventor: John F. Lown
  • Patent number: 5443826
    Abstract: A method of treating chronic disorders associated with the presence of abnormal microflora or an abnormal distribution of microflora in the gastrointestinal tract. The method involves the removal of at least a portion of the host's existing enteric microflora and the substitution of an effective amount of predetermined microflora. Pharmaceutical compositions which comprise viable microorganisms in a composition resembling the host's normal healthy faecal flora are also disclosed.
    Type: Grant
    Filed: August 6, 1993
    Date of Patent: August 22, 1995
    Inventor: Thomas J. Borody
  • Patent number: 5422393
    Abstract: A purified naturally occurring natriuretic compound, identified as Natriuretic Hormone, and a method for isolation of the compound. The natriuretic compound has a molecular weight of about 360, a molecular formula of C.sub.21 H.sub.28 O.sub.5 and with a steroidal nucleus. The compound is useful as a diuretic in the treatment of diseases such as heart disease and hypertension.
    Type: Grant
    Filed: October 12, 1993
    Date of Patent: June 6, 1995
    Assignee: Naturon Pharmaceutical Corporation
    Inventors: Neal S. Bricker, William J. Wechter
  • Patent number: 5304378
    Abstract: A novel wound dressing material is produced by a chemical treatment of animal fibers, particularly, wool, to strip off the keratin layers of the surfaces of the fibers so as to expose the non-keratin protein in the underlayers, which is hydrophilic. The wound dressing material provides healing and regenerating effects on the wounds, and can be produced at a low cost.
    Type: Grant
    Filed: July 26, 1991
    Date of Patent: April 19, 1994
    Assignee: Niigata Hi-Spinners Ltd.
    Inventors: Joichi Koga, Koichi Nomura, Hiroshi Hojo
  • Patent number: 5284833
    Abstract: Rationally designed wound cleanser that is physiologically compatible. The wound cleanser comprises a surfactant, an osmotic adjuster, a buffering agent, and water. The composition may also contain a preservative, a sudsing agent, a skin protectant, a pH adjuster, and a stabilizer.
    Type: Grant
    Filed: November 13, 1992
    Date of Patent: February 8, 1994
    Assignee: Carrington Laboratories, Inc.
    Inventors: Bill H. McAnalley, D. Eric Moore
  • Patent number: 5106630
    Abstract: A purified naturally occurring natriuretic compound, identified as Natriuretic Hormone, and a method for isolation of the compound. The natriuretic compound has a molecular weight of about 360, a molecular formula of C.sub.21 H.sub.28 O.sub.5 and with a steroidal nucleus. The compound is useful as a diuretic in the treatment of diseases such as heart disease and hypertension.
    Type: Grant
    Filed: June 13, 1990
    Date of Patent: April 21, 1992
    Assignee: Neal S. Bricker
    Inventors: Neal S. Bricker, William J. Wechter
  • Patent number: 5047249
    Abstract: This invention relates to activated protein-containing compositions comprising reducing agents, oxidizing agents and/or anti-oxidants and methods of use. The therapeutic compositions and methods of the present invention are particularly effective in promoting wound healing, and in inhibiting certain skin disorders, including eczema and seborrhea, sclerodema and acne. The therapeutic compositions and methods of the present invention have also shown enhanced effect as veterinary tools in reducing the debilitation associated with certain skin conditions in mammals including eczematoid dermatitis, chronic dermatitis, equine exuberant granuloma ("proud flesh"), decubitis ulcers, and canine cutaneous granulomas ("lick" granuloma).
    Type: Grant
    Filed: March 3, 1989
    Date of Patent: September 10, 1991
    Assignee: John Morris Co., Inc.
    Inventors: John Rothman, Philip A. Band
  • Patent number: 5004609
    Abstract: This invention discloses a fibrinophilic urokinase complex which is a complex of urokinase with a urokinase inhibitor or tissue activator inhibitor and has a molecular weight of 97,500.+-.3,000 and a method for the production of this fibrinophilic urokinase complex from urine. The urokinase complex can be used, as a thombolytic agent exhibiting an outstanding ability to dissolve thrombus.
    Type: Grant
    Filed: September 5, 1989
    Date of Patent: April 2, 1991
    Assignee: Shiseido Company Ltd.
    Inventors: Shigeru Hayashi, Kaneo Yamada
  • Patent number: 4990336
    Abstract: A multiphasic sustained release injectable delivery system is provided, as well as a method for treating humans and other mammals with that multiphasic sustained release system.
    Type: Grant
    Filed: February 8, 1989
    Date of Patent: February 5, 1991
    Assignee: BioSearch, Inc.
    Inventors: Loui J. Silvestri, H. Ruth Pyle
  • Patent number: 4959213
    Abstract: A pharmaceutical composition for the treatment and prevention of erythma and acne comprises in a pharmaceutically acceptable carrier from about 1 to 10 weight percent based on the total weight of the composition of a delipidized and purified keratin polymer obtained from animal starting material containing keratin, the keratin polymer being in the free state.
    Type: Grant
    Filed: September 14, 1987
    Date of Patent: September 25, 1990
    Assignee: L'Oreal
    Inventors: Joel Brod, Michel Kermici